13F
← All fund report cards

Saba Capital Management, L.P.

13F equity value
$3.1B
Positions
367
Top 10 concentration
49.4%
Quarters / total new picks
32 / 187
13F equity value over time
$0M$2.3T$4.6T2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +2.4% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 46.9% of quarters (excess t = -0.22, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
-0.6%
t-stat
-0.22
Quarterly win rate
47%
Annualized excess
-5.3%
$1 → follow vs universe
$1.40 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 1.14520180630: follow 1.00020180930: follow 1.07420181231: follow 1.17120190331: follow 1.09220190630: follow 1.04420190930: follow 1.27220191231: follow 0.88220200331: follow 1.13320200630: follow 1.18820200930: follow 1.45020201231: follow 1.18320210331: follow 1.19720210630: follow 1.16320210930: follow 1.19720211231: follow 1.07420220331: follow 1.04920220630: follow 0.98720220930: follow 0.98020221231: follow 0.81620230331: follow 0.87420230630: follow 1.02320230930: follow 1.11420231231: follow 1.08020240331: follow 1.60320240630: follow 1.78820240930: follow 2.00720241231: follow 1.33020250331: follow 1.45020250630: follow 1.51720250930: follow 1.39720251231: follow 1.402 0.75 1.50 2.25 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 367 · 2026 Q1

Ticker Value Weight QoQ
ECAT $299M
9.6%
TRIM
PDX $142M
4.5%
TRIM
XGDVX $138M
4.4%
TRIM
NFJ $129M
4.1%
ADD
BSTZ $123M
3.9%
ADD
GAM $108M
3.5%
TRIM
NBXG $97M
3.1%
HOLD
BPRE $79M
2.5%
ADD
PEO $63M
2.0%
TRIM
MEGI $60M
1.9%
TRIM
LEO $38M
1.2%
HOLD
MXF $37M
1.2%
ADD
FSK $36M
1.1%
NEW
RMT $34M
1.1%
ADD
LQD $33M
1.1%
ADD
DSM $31M
1.0%
HOLD
APO $30M
1.0%
NEW
HFRO $29M
0.9%
ADD
TSLA $29M
0.9%
ADD
GF $27M
0.9%
ADD

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.